JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bátai, I.
Right arrow Articles by Szabó, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bátai, I.
Right arrow Articles by Szabó, G.
Related Collections
Right arrow Regional Anesthesia
Right arrow Pharmacology
Anesth Analg 2002;94:729-731
© 2002 International Anesthesia Research Society

REGIONAL ANESTHESIA

Bacterial Growth in Ropivacaine Hydrochloride

Istvan Bátai, PhD*, Monika Kerényi, MD{dagger}, Judit Falvai*, and Gyorgy Szabó, PhD{ddagger}

*Department of Anesthesia and Intensive Care, {dagger}Department of Clinical Microbiology, {ddagger}Department of Orthopedic Surgery, University of Pécs, Pécs, Hungary

Address correspondence to Istvan Bátai, PhD, University of Pécs, Department of Anaesthesia and Intensive Care, Pécs, Szigeti u. 12., H-7624 Hungary. Address e-mail to ibatai{at}freemail.hu

IMPLICATIONS: Drugs affecting bacterial growth may influence the occurrence of postoperative infections. Ropivacaine 10 mg/mL killed Staphylococcus aureus and Escherichia coli; ropivacaine 2 mg/mL supported the growth of E. coli.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
E. Boselli, M. Guillier, J. Freney, M.-A. Mazoyer, E. Casoli, F. R. N. Renaud, T. Rimmele, D. Chassard, and B. Allaouchiche
Antibacterial Activity of Clonidine and Neostigmine In Vitro
Anesth. Analg., July 1, 2005; 101(1): 121 - 124.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
Z. Tamanai-Shacoori, V. Shacoori, J.-M. Vo Van, J.-C. Robert, and M. Bonnaure-Mallet
Sufentanil modifies the antibacterial activity of bupivacaine and ropivacaine: [Le sufentanil modifie l'activite antibacterienne de la bupivacaine et de la ropivacaine]
Can J Anesth, November 1, 2004; 51(9): 911 - 914.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. Kampe, C. Poetter, S. Buzello, H.-M. Wenchel, M. Paul, P. Kiencke, and S.-M. Kasper
Ropivacaine 0.1% with Sufentanil 1 {micro}g/mL Inhibits In Vitro Growth of Pseudomonas Aeruginosa and Does Not Promote Multiplication of Staphylococcus Aureus
Anesth. Analg., August 1, 2003; 97(2): 409 - 411.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2002 by the International Anesthesia Research Society.